TransEnterix, Inc. (NYSE:TRXC) is on recovery track with 39.87% gain from a 1-year low price of $1.58. The company lost -5.15% to attain the price of $2.21 on 3/12/2019. Throughout the recent session, the prices were hovering between $2.2 and $2.34. These shares are 92.31% off its target price of $4.25 and the current market capitalization stands at $487.57M. The recent change has given its price a -16.71% deficit over SMA 50 and -68.34% deficit over its 52-week high. The stock witnessed -12.99% declines, -26.82% declines and -60.04% declines for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found TRXC’s volatility during a week at 6.04% and during a month it has been found around 7.4%.

TransEnterix, Inc. (TRXC) Top Holders

Institutional investors currently hold around $175 million or 36.2% in TRXC stock. Look at its top three institutional owners: Blackrock Inc. owns $31.97 million in TransEnterix, Inc., which represents roughly 6.56% of the company’s market cap and approximately 18.27% of the institutional ownership. Similar statistics are true for the second largest owner, Vanguard Group Inc, which owns 7,733,244 shares of the stock are valued at $18.02 million. The third largest holder is Jpmorgan Chase & Co, which currently holds $18.01 million worth of this stock and that ownership represents nearly 3.69% of its market capitalization.

TransEnterix, Inc. 13F Filings

At the end of December reporting period, 73 institutional holders increased their position in TransEnterix, Inc. (NYSE:TRXC) by some 9,961,711 shares, 78 decreased positions by 6,993,609 and 32 held positions by 58,212,634. That puts total institutional holdings at 75,167,954 shares, according to SEC filings. The stock grabbed 31 new institutional investments totaling 3,672,080 shares while 31 institutional investors sold out their entire positions totaling 2,654,318 shares.

TransEnterix, Inc. (TRXC) Analyst Guide

Several analysts have released their opinion on TransEnterix, Inc. (NYSE:TRXC), with 2 analysts believing it is a strong buy. Whereas 2 of them predict the stock is a hold. Also, there are 1 buy, 0 sell and 0 strong sell ratings, collectively assigning a 2 average brokerage recommendation [T1].